PureTech Health announces first patient dosing in Celea phase 3 trial
13th Jul 2026 10:17
(Alliance News) - PureTech Health PLC on Monday said its founded entity Celea Therapeutics has announced the first dosing in a phase 3 trial. Read More
| Price | 119.00p on 03-08-2026 at 05:00:10 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.00p |
| Sell | 0.00p |
| Last Trade: | Buy 80,000.00 at 119.119p |
| Day's Volume: | 0 |
| Last Close: | 119.00p |
| Open: | 0.00p |
| ISIN: | GB00BY2Z0H74 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 104.80p - 142.80p |
| Market Capitalisation: | £289.67m |
| VWAP: | 0.00p |
| Shares in Issue: | 243.42m |
PureTech (PRTC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 80,000 | 119.119p | Suspected BUY Trade |
16:50:28 - 31-Jul-26 |
| Sell* | 224,529 | 119.00p | Uncrossing Trade |
16:35:06 - 31-Jul-26 |
| Sell* | 689 | 118.40p | Automatic Execution |
16:28:31 - 31-Jul-26 |
| Buy* | 76 | 118.611p | Suspected BUY Trade |
16:28:08 - 31-Jul-26 |
| Sell* | 581 | 118.40p | Automatic Execution |
16:26:51 - 31-Jul-26 |
| Buy* | 141 | 119.00p | Automatic Execution |
16:25:53 - 31-Jul-26 |
| Sell* | 142 | 118.40p | Automatic Execution |
16:25:47 - 31-Jul-26 |
| Sell* | 1,172 | 118.60p | Automatic Execution |
16:25:47 - 31-Jul-26 |
| Sell* | 272 | 118.60p | Automatic Execution |
16:25:47 - 31-Jul-26 |
| Buy* | 2,834 | 119.00p | Automatic Execution |
16:22:04 - 31-Jul-26 |
PureTech (PRTC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Jul 2026 5:00 pm | RNS | PDMR Notification RSU Vesting |
| 17th Jul 2026 5:00 pm | RNS | PDMR Notification RSU Vesting |
| 13th Jul 2026 7:00 am | RNS | PRTC: Celea Doses 1st Patient in Phase 3 IPF Trial |
| 9th Jul 2026 7:00 am | RNS | Director/PDMR Shareholding |
| 2nd Jul 2026 7:01 am | RNS | PRTC Launches Celea w/ $180M & Top Tier Syndicate |
| 2nd Jul 2026 7:00 am | RNS | PRTC Launches Celea: $180M & Asset Transfer |
| 10th Jun 2026 5:38 pm | RNS | Result of AGM |
| 9th Jun 2026 7:00 am | RNS-R | PRTC's SPTX: New Positive GlyphAgo Ph1 Dosing Data |
| 4th Jun 2026 5:37 pm | RNS | Holding(s) in Company |
| 29th May 2026 5:00 pm | RNS | Holding(s) in Company |